---
layout: post
title: "Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request"
date: 2026-02-05 19:09:30 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-09750
original_published: 2024-05-06 00:00:00 +0000
significance: 8.00
---

# Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** May 06, 2024 00:00 UTC
**Document Number:** 2024-09750

## Summary

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the second cycle of the Medicare Drug Price Negotiation Program and manufacturer effectuation of the maximum fair price for 2026 and 2027 for the implementation of the Inflation Reduction Act. This and other Inflation Reduction Act-related guidance can be viewed on the dedicated Inflation Reduction Act section of the CMS website at https://www.cms.gov/inflation-reduction-act-and-medicare/.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/05/06/2024-09750/inflation-reduction-act-ira-medicare-drug-price-negotiation-program-draft-guidance-comment-request)
- API: https://www.federalregister.gov/api/v1/documents/2024-09750

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
